相关实验视频

Updated: May 20, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

针对PSMA的放射性核素治疗方法的进展

Samuel Ruder¹, Andres Ricaurte-Fajardo², Michael Sun³

¹Department of Medicine, Division of Hematology and Oncology, New York Presbyterian Weill Cornell Medical Center, 520 East 70th Street, Starr Pavilion, NY, NY, 10065, USA. spj9003@nyp.org.

Current treatment options in oncology

|March 26, 2025

概括

像177Lu-PSMA-617这样的前列腺特异性膜抗原向放射性核素疗法 (PSMA-TRT) 对前列腺癌具有前景. 研究正在探索它们在早期阶段的使用和组合疗法,以获得更好的结果.

科学领域:

在瘤学瘤学.
核医学就是核医学.
放射性药物疗法是一种放射性药物疗法.

背景情况:

前列腺特异性膜抗原向放射性核素疗法 (PSMA-TRT) 为前列腺癌治疗提供了新的希望.
177Lu-PSMA-617是FDA批准的转移性割抵抗性前列腺癌 (mCRPC),标志着一个重要的治疗进步.

研究的目的:

审查PSMA-TRT在前列腺癌管理中的当前状态和未来方向.
突出177Lu-PSMA-617在各种疾病阶段和治疗组合中的潜力.

主要方法:

对临床试验数据的审查,包括VISION和PSMAfore试验.
讨论新出现的放射性核酸和PSMA-TRT的输送工具.
探索组合疗法和预测生物标志物的探索.

主要成果:

177Lu-PSMA-617在ARPI和税治疗后的mCRPC患者中显示出改善的无进展生存率 (rPFS) 和整体生存率 (OS).
早期应用和组合策略正在积极调查中,有希望的初步发现.

结论:

PSMA-TRT,特别是177Lu-PSMA-617,是一个快速发展的领域,有可能显著改善前列腺癌的结果.
未来的研究重点是预测生物标志物,剂量测量和新的治疗组合,将是优化PSMA-TRT在前列腺癌治疗中的作用的关键.

关键词:

177Lu-PSMA-61717 这是一个很好的方法.转移性割抵抗性前列腺癌 (mCRPC) 是一种用PSMA向治疗的治疗方法.前列腺癌是什么意思前列腺癌是什么意思放射性合物治疗是一种放射性合物治疗.放射性核酸治疗是一种放射性核酸疗法.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET